Business Wire

A Defining Moment for Tobacco Harm Reduction: FEELM Shares the Stage With Industry Giants to Reducing Smoking Rates and Save Lives

Share

FEELM, the flagship atomization technology brand belonging to SMOORE – a global leader in atomisation technology solutions – today joined global health advocates, leading scientists, politicians, and industry experts at a virtual conference on tobacco harm reduction.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230427005527/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

(Photo: Business Wire)

IN FOCUS, an annual half-day event organised by the Global Tobacco and Nicotine Forum (GTNF) which aims to consider key issues affecting the sector, this year returned to the theme of addressing tobacco harm reduction, and how best to support smokers to transition to reduced-risk products, including vapes, heat-not-burn products, and oral nicotine.

Ahead of the virtual conference, FEELM representatives spoke at a breakfast event in central London alongside Andrew Lewer MBE MP, the Vice Chair of the UK Parliament’s All-Party Parliamentary Group for Vaping, as well as Delon Human, the President of Health Diplomats and a former Secretary-General of the World Medical Association.

The UK Government has consistently set out that its harm reduction strategy centres around the use of vaping as a tool for smoking cessation, and in encouraging existing smokers to transition to a less harmful alternative. Since 2015, Public Health England (now the Office for Health Improvement and Disparities) has been clear that vaping is at least 95 per cent less harmful than smoking, after a review of all available independent and peer-reviewed research. This was supported by a further review of the evidence in 2018, and by Dr Javed Khan in his independent report last year into “making smoking obsolete”, as well as in the recent speech earlier this month by the Minister for Public Health, Neil O’Brien MP.

However, concerns have been raised about the growth in the availability of illegal and non-compliant vapes, as well as the increased rates of youth access to nicotine products. As a global leader of atomisation technology solutions, FEELM is focused on ensuring compliance with all regulations in the markets where it operates, and supporting its industry clients through research investment and technological innovation.

Echo Liu, FEELM’s European Division Director, said:

"We welcome the UK Government's ongoing recognition of the potential that vaping has to achieve its ambitions for a smoke-free future, and we are committed to working with regulators and the wider industry to address the key challenges the sector faces."

"Our vaping solutions have been widely adopted in more than fifty markets – including the UK, France, and Germany – and these are helping millions of smokers to improve their health by switching to vaping."

FEELM’s disposable ceramic coil technologies have already been launched in markets like France, UK, Belgium, on behalf of their clients, and will soon be available in other key markets. The FEELM MAX solution, which offers more puffs, greater taste consistency, and a fully visible e-liquid measure, is the best disposable available which ensures regulatory compliance.

FEELM will be launching its FEELM MAX at the Birmingham Vaper Expo on 13 May.

About FEELM:

As a flagship OEM technology brand belonging to SMOORE, FEELM is the world’s leading closed vape system solution provider. Through its ceramic coil heating technology, used in around one in every two closed pods sold globally, FEELM provides its vaping solutions to b2c companies in fifty countries worldwide, including RELX, HEXA, KIWI, and NJOY, among others.

About SMOORE:

SMOORE is the global leader in offering vaping technology solutions, including manufacturing OEM vaping devices and vaping components for heat-not-burn products, with advanced R&D technology, strong manufacturing capacity, wide-spectrum product portfolio, and a diverse customer base.

About GTNF:

The Global Tobacco & Nicotine Forum (GTNF) is the world’s leading annual forum discussing the future of the tobacco and nicotine industries. From its launch in Rio de Janeiro in 2008 to the present day, the GTNF has become the global exchange for views and ideas between public health experts, government representatives, the industry, and investors.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For more information or journalist queries, please contact Tommy Gilchrist on 0044 7388 110 679 or via tommy@davidroach.co.uk

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SCENTMATIC's AI "KAORIUM" Debuts at THAMEEN Fragrance Launch in London's Selfridges4.7.2025 12:13:00 EEST | Press release

SCENTMATIC Inc., a leader in scent digitalization, introduced its AI-powered scent-to-language system, KAORIUM, at the THAMEEN Fragrance new product launch event. This pivotal event took place from June 5 to 11, 2025, at Selfridges department store in London, UK. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250703662207/en/ State of exhibition Global Expansion: KAORIUM Establishes UK Presence Europe leads the global fragrance market, with the UK projected to reach US$2.82 billion by 2033. Recognizing this, SCENTMATIC is rapidly expanding its international footprint. In May 2024, SCENTMATIC established its overseas subsidiary, KAORIUM, in London, appointing industry expert Ben Yanoushek as CEO. Official UK operations commenced on February 1, 2025, with the launch of its dedicated website: www.kaorium.com. KAORIUM Trialed at "Florentine Diamond" Launch Event The "Florentine Diamond" launch event for luxury brand THAMEEN Frag

Global Tourism Surging Ahead of Economic Growth, With Visits to Hit 30 Billion by 20344.7.2025 02:00:00 EEST | Press release

The World Economic Forum has today published a new report forecasting that the travel and tourism industry is projected to serve 30 billion tourist trips by 2034. Travel and Tourism at a Turning Point: Principles for Transformative Growth, produced in collaboration with Kearney and the Ministry of Tourism Saudi Arabia, reveals a projected $16 trillion contribution to global GDP by the same year—representing more than 11% of the total world economy, according to World Travel & Tourism Council estimates. The report also found that the sector is expanding 1.5 times faster than the global economy, generating significant commercial opportunities as long as the mounting challenges of climate change, labour shortages and infrastructure gaps are addressed. Inbound and outbound trips increasing fast Asia is on track to become the world’s fastest-growing tourism economy, with the direct travel and tourism GDP contribution expected to exceed 7% across the region by 2034. Notably, India and China

The 2025-2026 World Branding Awards Animalis Edition Honouring Leading Pet and Animal Brands Globally3.7.2025 22:00:00 EEST | Press release

The 2025-2026 World Branding Awards Animalis Edition marked its fifth instalment, bringing together leading pet and animal brands from all around the world. These brands were celebrated for their outstanding achievements, earning recognition as National, Regional, and Global Winners. The awards ceremony, held at Vienna's prestigious Hofburg Palace, welcomed winners across diverse categories, including pet food, retail, wellness, pet exhibitions, and aquatic products. Mounia Berrada-Gouzi expertly hosted the evening, which culminated in a grand celebration of brand excellence. “The Animalis Edition of the World Branding Awards recognises brands that have achieved the highest distinction—genuine recognition in the hearts and minds of consumers. Tonight, we honour those whose names resonate globally, whose values inspire loyalty, and whose presence defines excellence in the pet and animal industry,” said Richard Rowles, Chairman of the World Branding Forum. Out of over 950 brands nominate

Venture Global Announces 20-Year Sales and Purchase Agreement with PETRONAS3.7.2025 15:59:00 EEST | Press release

Today, Venture Global, Inc. (NYSE: VG) announced the execution of a new 20-year Sales and Purchase Agreement (SPA) with PETRONAS LNG Ltd. (PLL), a subsidiary of the Malaysian state-owned oil and gas company, PETRONAS. Under the terms of the SPA, PETRONAS will purchase 1 million tonnes per annum (MTPA) of liquefied natural gas (LNG) from Venture Global’s third facility, CP2 LNG, for 20 years. This builds upon Venture Global’s existing agreement with PETRONAS for 1 MTPA of LNG supply from Plaquemines LNG. PETRONAS, a world-class partner in the LNG industry, joins other CP2 LNG customers in Europe, Asia and the rest of the world in a strategically important project to global energy supply and security. To date, approximately 10.75 MTPA of the 14.4 MTPA nameplate capacity for CP2 Phase One has been sold. About Venture Global Venture Global is a long-term, low-cost provider of U.S. LNG sourced from resource rich North American natural gas basins. Venture Global’s business includes assets ac

Frost & Sullivan Recognizes Novotech as 2025 Global Biotech CRO Company of the Year3.7.2025 15:05:00 EEST | Press release

In recognition of its innovation, client-focused delivery, and global impact, Novotech has been awarded the 2025 Global Biotechnology Contract Research Organization (CRO) Company of the Year by Frost & Sullivan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250703950144/en/ Novotech Wins Global CRO Award Novotech is a globally recognized full-service clinical CRO and scientific advisory firm, trusted by biotech and small- to mid-sized pharmaceutical companies to advance their drug development programs at every phase. With a global footprint spanning Asia-Pacific, North America, and Europe, Novotech supports over 5,000 clinical trial sites and a distributed team of experts delivering seamless, end-to-end solutions across geographies. “Novotech is redefining biotech-focused clinical research through AI-driven innovation, global expansion, and a client-embedded partnership model. With a clear vision to be the CRO of choice for

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye